Covered recipient · General Payments record
EREZ ABRAHAM MINKA
Allopathic & Osteopathic Physicians Dermatology MOHS-Micrographic Surgery
General Payments · PY2018–2024
$2,480.04
- Reported across 127 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $234.83 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $67.11 | 4 |
| Kerecis Limited | $30.96 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $29.30 | 2 |
| Biofrontera Inc. | $25.63 | 2 |
| GENZYME CORPORATION | $19.27 | 1 |
| Amgen Inc. | $17.60 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.98 | 1 |
| Dermavant Sciences, Inc. | $15.81 | 1 |
| ConvaTec Inc. | $13.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $17.60 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117329570 | CMS |
| Biofrontera Inc. | $14.36 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092759303 | CMS |
| Biofrontera Inc. | $11.27 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093025921 | CMS |
| ConvaTec Inc. | $13.17 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151380413 | CMS |
| Dermavant Sciences, Inc. | $15.81 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127907746 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.98 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101646203 | CMS |
| GENZYME CORPORATION | $19.27 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139831990 | CMS |
| Kerecis Limited | $30.96 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120106085 | CMS |
| Lilly USA, LLC | $15.68 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134966311 | CMS |
| Lilly USA, LLC | $14.20 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136161313 | CMS |
| Lilly USA, LLC | $18.28 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136161315 | CMS |
| Lilly USA, LLC | $18.95 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134965401 | CMS |
| Novartis Pharmaceuticals Corporation | $16.00 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086980352 | CMS |
| Novartis Pharmaceuticals Corporation | $13.30 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086980362 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.